Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.43 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.43 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.43 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.43 |
| ▸ | DUT | P33316 | 15/20 | 0.39 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.37 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5671911 | 0.89 | SLC28A1 (0.35) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| SCHEMBL1999188 | 0.86 | SLC28A1 (0.48) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL7524822 | 0.86 | P2RY2 (0.36) | DUTP2RY14 | |
| SCHEMBL29834207 | 0.83 | SLC28A1 (0.35) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| SCHEMBL18049495 | 0.83 | SLC28A1 (0.32) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| SCHEMBL7209223 | 0.82 | SLC28A1 (0.32) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| Phosphoric Acid SCHEMBL21465157 | 0.82 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL3827540 | 0.81 | SLC28A1 (0.42) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| SCHEMBL7209224 | 0.80 | SLC28A1 (0.33) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| SCHEMBL11430666 | 0.78 | LMNA (0.45) | SLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5410033-A | Deoxygenation of cis vicinal diols to make didehydro dideoxy nucleosidies and synthetic intermediates | TEROCHEM LABORATORIES LIMITED (CA) | 1995-04-25 | — | — | US | claimed |
| CN-109134570-A | The preparation method of C4 '-fluoro Uridine phosphoramidite monomer and C4 '-fluoro uridine modification RNA | 南开大学 | 2019-01-04 | — | — | CN | disclosed |
| US-7507859-B2 | Functional synthetic molecules and macromolecules for gene delivery | FIFTH BASE LLC (US) | 2009-03-24 | — | — | US | disclosed |
| EP-1644479-A4 | FUNCTIONAL SYNTHETIC MOLECULES AND MACROMOLECULES FOR GENE DELIVERY | GRINSTAFF MARK W (US) | 2008-04-23 | — | — | EP | disclosed |
| CN-101130540-A | Nucleoside derivative containing selenium and its preparation method | UNIV SHANGHAI JIAOTONG (CN) | 2008-02-27 | — | — | CN | disclosed |
| US-20060241071-A1 | Functional synthetic molecules and macromolecules for gene delivery | FIFTH BASE LLC | 2006-10-26 | — | — | US | disclosed |
| EP-1644479-A2 | FUNCTIONAL SYNTHETIC MOLECULES AND MACROMOLECULES FOR GENE DELIVERY | Grinstaff, Mark, W. (US) | 2006-04-12 | — | — | EP | disclosed |
| WO-2005007810-A2 | FUNCTIONAL SYNTHETIC MOLECULES AND MACROMOLECULES FOR GENE DELIVERY | GRINSTAFF MARK W (US) | 2005-01-27 | — | — | WO | disclosed |
| CN-1020106-C | Process for pyrimidine derivatives | HOFFMANN LA ROCHE (CH) | 1993-03-17 | — | — | CN | disclosed |
| EP-0316017-A2 | 2',3'-Dideoxy-2'-fluoronucleosides | Bristol-Myers Squibb Company (US) | 1989-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060241071-A1 | Functional synthetic molecules and macromolecules for gene delivery | ANXA6, STING1, POLRMT | SLC28A1 1592/4885SLC28A2 1890/4885SLC29A1 397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.